How does your program reduce my risk of nausea?
Our treatment protocol is designed to maintain GLP-1 effectiveness while minimizing the risk of nausea. For individuals more prone to nausea, we prescribe compounded Semaglutide with Vitamin B6, which has been scientifically shown to help reduce nausea and fatigue in patients taking GLP-1 medications. Additionally, our twice-weekly split dosing schedule further reduces the likelihood of intolerance, promoting better treatment adherence and patient comfort.
Semaglutide (7.92mg)
Semaglutide is a derivative of the naturally occurring GLP-1, a peptide known to lower blood sugar levels and enhance insulin secretion. Research shows that Semaglutide may also improve heart, liver, and lung function while helping to slow or prevent the effects of Alzheimer’s disease. Semaglutide has been shown to significantly decrease appetite by delaying gastric emptying and reducing intestinal motility. Glucagon-Like Peptide-1 (GLP-1) Analog Shown to Stimulate Insulin and Suppress Glucagon Secretion in a Glucose-Dependent Manner.
Retatrutide (36mg)
​Retatrutide enhances glucagon production, leading to the breakdown of stored fats and glycogen, thereby increasing basal metabolism for more consistent fat loss. Its actions on GLP-1 and GIP receptors promote delayed gastric emptying and appetite control, offering a comprehensive approach to obesity research distinct from older GLP-1 agonists.
Compounded Semaglutide (GLP-1)
Compounded Semaglutide + Vitamin B6 to Minimize Nausea
Made in State Board of Pharmacy or FDA-licensed Facilities
Safe & Effective Non-Sodium Formulation
Average 5% Body Weight loss Over 12 Weeks
*individual results vary
Prescribed by a State-Licensed Provider
Insurance Not Required
Tirzepatide (45mg)
Tirzepatide is a synthetic compound derived from gastric inhibitory polypeptide (GIP), with the added functionality of glucagon-like peptide-1 (GLP-1). By combining these properties, Tirzepatide effectively reduces blood glucose levels, improves insulin sensitivity, enhances satiety, and promotes weight loss. While originally developed as a treatment for type 2 diabetes, Tirzepatide has also demonstrated the ability to protect the cardiovascular system and act as a potent agent for weight reduction.
about
About Semaglutide / Cyanocobalamin Injection
Semaglutide
Semaglutide / Cyanocobalamin Injection is a compounded medication that combines two distinct therapeutic agents to address metabolic health and nutritional support in a single formulation. This compounded preparation is available exclusively through our 503A compounding pharmacy pursuant to a patient-specific prescription and is tailored for individual patients based on their specific needs as determined by the prescribing physician.